Luke Evnin's Net Worth

$3.08 Billion

Who is Luke Evnin?

Luke Evnin has an estimated net worth of $3.08 Billion. This is based on reported shares across multiple companies, which include RHYTHM PHARMACEUTICALS, INC., ARYx Therapeutics, Inc., PEPLIN INC, CRYOCOR INC, HEMOSENSE INC, COTHERIX INC, TERCICA INC, BARRIER THERAPEUTICS INC, TriVascular Technologies, Inc., RIGEL PHARMACEUTICALS INC, Entrada Therapeutics, Inc., Dyne Therapeutics, Inc., PHARMATHENE, INC, AVEO PHARMACEUTICALS INC, XCYTE THERAPIES INC, PONIARD PHARMACEUTICALS, INC., ACORDA THERAPEUTICS INC, ARATANA THERAPEUTICS, INC., KALOBIOS PHARMACEUTICALS INC, Conatus Pharmaceuticals Inc, Epizyme, Inc., Cerecor Inc., CRITICAL THERAPEUTICS INC, Pharmasset Inc, Zalicus Inc., AFFYMAX INC, Somaxon Pharmaceuticals, Inc., HELICOS BIOSCIENCES CORP, SENORX INC, OSCIENT PHARMACEUTICALS CORP, Alsius Corp, Omrix Biopharmaceuticals, Inc., MEMORY PHARMACEUTICALS CORP, Harpoon Therapeutics, Inc., VIACELL INC, METROPCS COMMUNICATIONS INC, EnteroMedics Inc, iTeos Therapeutics, Inc., Restore Medical, Inc., Radius Health, Inc., Repare Therapeutics Inc., Verastem, Inc., Syndax Pharmaceuticals Inc, Pacira Pharmaceuticals, Inc., TCR2 THERAPEUTICS INC., TURMERIC ACQUISITION CORP., Werewolf Therapeutics, Inc., Oncorus, Inc., IPASS INC, CHIASMA, INC, IDENIX PHARMACEUTICALS INC, and METABASIS THERAPEUTICS INC.

SEC CIK

Luke Evnin's CIK is 0001134657

Past Insider Trading and Trends

2007 was Luke Evnin's most active year for acquiring shares with 35 total transactions. Luke Evnin's most active month to acquire stocks was the month of June. 2021 was Luke Evnin's most active year for disposing of shares, totalling 100 transactions. Luke Evnin's most active month to dispose stocks was the month of August. 2019 saw Luke Evnin paying a total of $14,121,250.25 for 8,076,674 shares, this is the most they've acquired in one year. In 2007 Luke Evnin cashed out on 44,712,617 shares for a total of $98,290,150.02, their largest year based on trade value.